Literature DB >> 26515846

Pityriasis rubra pilaris occurring after vaccination with diphtheria-pertussis-tetanus and oral poliovirus vaccines.

Mariem Mohamed1, Hichem Belhadjali, Faten Hammedi, Chebil Ben Meriem, Jameleddine Zili.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26515846     DOI: 10.4103/0378-6323.168326

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  7 in total

1.  Pityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.

Authors:  M K Hunjan; C Roberts; S Karim; J Hague
Journal:  Clin Exp Dermatol       Date:  2021-09-24       Impact factor: 4.481

2.  A case of pityriasis rubra pilaris following AstraZeneca COVID-19 vaccine.

Authors:  Miki Wada; Senhong Lee; Paul Curnow; Ian Simpson; Adrian Mar
Journal:  JAAD Case Rep       Date:  2022-05-02

3.  Pityriasis rubra pilaris potentially triggered by messenger RNA-1273 COVID vaccine.

Authors:  Etsubdenk M Ajebo; John D Howard; Dipti Anand; Loretta S Davis
Journal:  JAAD Case Rep       Date:  2022-04-01

4.  Ixekizumab successfully treated severe pityriasis rubra pilaris after COVID-19 vaccination.

Authors:  Ya-Ting Liu; Shang-Shang Wang
Journal:  Skin Health Dis       Date:  2022-06-16

5.  Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.

Authors:  Nika Hlaca; Tina Zagar; Marija Kastelan; Sandra Peternel; Ines Brajac; Katarina Dujmovic-Hasanbegovic; Larisa Prpic-Massari
Journal:  Dermatol Ther       Date:  2022-08-27       Impact factor: 3.858

6.  Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine.

Authors:  I Lladó; B Butrón; R Sampedro-Ruiz; J Fraga; D de Argila
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-12       Impact factor: 9.228

7.  Pityriasis rubra pilaris (type I) following ChAdOx1 COVID-19 vaccine: A report of two cases with successful treatment with oral isotretinoin.

Authors:  P R Criado; M Ianhez; P S Rocha; H A Miot
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-15       Impact factor: 9.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.